Eli Financial Statements From 2010 to 2025

LLY Stock   746.90  10.30  1.40%   
Eli Lilly financial statements provide useful quarterly and yearly information to potential Eli Lilly and investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Eli Lilly financial statements helps investors assess Eli Lilly's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Eli Lilly's valuation are summarized below:
Eli Lilly and does not presently have any fundamental signals for analysis.
Check Eli Lilly financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eli Lilly's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eli financial statements analysis is a perfect complement when working with Eli Lilly Valuation or Volatility modules.
  
This module can also supplement various Eli Lilly Technical models . Check out the analysis of Eli Lilly Correlation against competitors.

Eli Lilly and Company Price To Book Analysis

Eli Lilly's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Eli Lilly Price To Book

    
  33.65 X  
Most of Eli Lilly's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eli Lilly and is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Based on the latest financial disclosure, Eli Lilly and has a Price To Book of 33.6544 times. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The price to book for all Germany stocks is notably lower than that of the firm.

Eli Lilly Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Eli Lilly's current stock value. Our valuation model uses many indicators to compare Eli Lilly value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eli Lilly competition to find correlations between indicators driving Eli Lilly's intrinsic value. More Info.
Eli Lilly and is rated below average in current valuation category among its peers. It is rated fifth overall in price to book category among its peers . The ratio of Current Valuation to Price To Book for Eli Lilly and is about  10,024,250,504 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eli Lilly's earnings, one of the primary drivers of an investment's value.

About Eli Lilly Financial Statements

Eli Lilly shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Eli Lilly investors may analyze each financial statement separately, they are all interrelated. The changes in Eli Lilly's assets and liabilities, for example, are also reflected in the revenues and expenses on on Eli Lilly's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.